Growth Metrics

Bioventus (BVS) Other Non-Current Liabilities (2020 - 2026)

Bioventus filings provide 6 years of Other Non-Current Liabilities readings, the most recent being $15.3 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 33.56% to $15.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.3 million, a 33.56% decrease, with the full-year FY2025 number at $15.3 million, down 33.56% from a year prior.
  • Other Non-Current Liabilities hit $15.3 million in Q4 2025 for Bioventus, down from $20.5 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $30.9 million in Q3 2023 to a low of $15.3 million in Q4 2025.
  • Median Other Non-Current Liabilities over the past 5 years was $22.8 million (2022), compared with a mean of $23.4 million.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 44.57% in 2022 and later soared 72.58% in 2023.
  • Bioventus' Other Non-Current Liabilities stood at $16.3 million in 2021, then grew by 6.75% to $17.4 million in 2022, then soared by 60.25% to $27.9 million in 2023, then decreased by 17.3% to $23.1 million in 2024, then tumbled by 33.56% to $15.3 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $15.3 million (Q4 2025), $20.5 million (Q3 2025), and $21.3 million (Q2 2025) per Business Quant data.